return to news
  1. Stocks to watch in Wednesday's trade

Stocks to watch in Wednesday's trade

blog author image


blog verification badge

2 min read • Updated: March 13, 2024, 9:06 AM

Facebook PageTwitter PageLinkedin Page


Indian inflation numbers came in little changed, while US inflation also increased moderately. US markets reacted positively on slight increase in the inflation.

Asian markets are trading mixed on Wednesday morning

Indian markets are expected to open flat today due to mixed cues from Asian peers. Global markets digested a slight increase in US inflation, with the US S&P 500 and Nasdaq closing higher by more than 1%, while the Dow Jones closed 0.61% higher. Indian inflation numbers for February remained relatively unchanged at 5.09%, compared to 5.1% in January 2024. Here are some key stock developments to watch out for:


According to Bloomberg, the British American Tobacco, has confirmed that the British cigarette maker will sell a 3.5% equity stake via a block deal to institutional investors at discount to the current market price. The overall stake sale is valued at ₹16,775 crore.

HG Infra & Engineering

The company has received additional orders worth ₹709 crore from the East Central Railway. These orders include the construction of double-line tracks (3rd & 4th line), formation including earthwork, blanketing, minor bridges, major bridges, electrification works, and other miscellaneous works.

Allcargo Logistics

The company reported its monthly volume numbers for February through an exchange filing. The total LCL volumes for the month of February increased by 7% year-over-year.

Muthoot Capital

The company has entered into a partnership with Greaves Finance, a 100% EV finance arm of Greaves Cotton, for financing two-wheeler EVs across India.

CG Power

CG Power, in a joint venture with Renesas Electronics and Star Microelectronics, has performed a foundation stone ceremony in Sanand for a world-class OSAT facility in India. The facility is being developed at a cost of ₹7,600 crores.

Glenmark Pharmaceuticals

The company has completed transfer of 20% stake in Glenmark life sciences to Nirma.